Literature DB >> 12421161

Brain blood flow in the nitroglycerin (GTN) model of migraine: measurement using positron emission tomography and transcranial Doppler.

E M Bednarczyk1, D S Wack, M Y Kassab, K Burch, K Trinidad, M Haka, J Gona.   

Abstract

Nitroglycerin has been widely used as a model of experimental migraine. Studies combining measurement of flow velocity using transcranial Doppler (TCD) concurrently with measures of cerebral blood flow (CBF) are uncommon. We report the results of a study combining TCD and positron emission tomography (PET). Healthy volunteers with no personal or family history of migraine underwent measurement of CBF using H215O PET, and velocity using TCD. Measurements were done at baseline, and following i.v. nitroglycerin at 0.125, 0.25 and 0.5 micro g/kg per min. Subcutaneous sumatriptan (6 mg) was injected, with CBF and velocity measured 15, 30, and 60 min later. Nitroglycerin was terminated and measurements obtained 30 min later. Six male and six female subjects were studied. Nitroglycerin increased global CBF while flow velocities decreased. Sumatriptan did not have a significant effect on these values. Regions of increased flow included the anterior cingulate, while regions of decreased flow included the occipital cortex. Our data suggest that nitroglycerin induces regional changes in CBF that are similar to changes reported in spontaneous migraine, but produces distinctly different effects on global CBF and velocity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12421161     DOI: 10.1046/j.1468-2982.2002.00440.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  10 in total

Review 1.  Acupuncture analgesia in migraine.

Authors:  Gen-cheng Wu
Journal:  Chin J Integr Med       Date:  2009-08-18       Impact factor: 1.978

Review 2.  Modelling headache and migraine and its pharmacological manipulation.

Authors:  S E Erdener; T Dalkara
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

3.  Intravenous Infusion of Nitroglycerine Leads to Increased Permeability on Dynamic Contrast-Enhanced MR Imaging in Pig Brains.

Authors:  J Carl; D A Tideman; S Ravn; K Lund; S O Magnisdottir; B Kjærgaard
Journal:  AJNR Am J Neuroradiol       Date:  2015-03-26       Impact factor: 3.825

4.  Sodium nitroprusside dilates cerebral vessels and enhances internal carotid artery flow in young men.

Authors:  Niels D Olesen; Mads Fischer; Niels H Secher
Journal:  J Physiol       Date:  2018-07-04       Impact factor: 5.182

5.  Nitric oxide-induced headache may arise from extracerebral arteries as judged from tolerance to isosorbide-5-mononitrate.

Authors:  Ingelise Christiansen; Helle K Iversen; Jes Olesen; Peer Tfelt-Hansen
Journal:  J Headache Pain       Date:  2008-06-03       Impact factor: 7.277

6.  Intracranial hemodynamics during intravenous infusion of glyceryl trinitrate.

Authors:  H K Iversen; S Holm; L Friberg; P Tfelt-Hansen
Journal:  J Headache Pain       Date:  2008-04-10       Impact factor: 7.277

Review 7.  New insights into headache: an update on functional and structural imaging findings.

Authors:  Arne May
Journal:  Nat Rev Neurol       Date:  2009-04       Impact factor: 42.937

8.  Relationship between Nitrate-Induced Headache and Coronary Artery Lesion Complexity.

Authors:  Hakan Erkan; Gülhanım Kırış; Levent Korkmaz; Mustafa Tarık Ağaç; İsmail Gökhan Çavuşoğlu; İhsan Dursun; Ahmet Seyda Yılmaz; Ahmet Oğuz Aslan; Dilek Cahide Kırcı; Şükrü Çelik
Journal:  Med Princ Pract       Date:  2015-07-09       Impact factor: 1.927

9.  Transcranial Doppler measurements in migraine and nitroglycerin headache.

Authors:  Mounzer Y Kassab; Arshad Majid; Omid Bakhtar; Muhammad U Farooq; Kamakshi Patel; Edward M Bednarczyk
Journal:  J Headache Pain       Date:  2007-10-23       Impact factor: 7.277

10.  Endothelial nitric oxide synthase (-786T>C) polymorphism and migraine susceptibility: A meta-analysis.

Authors:  Han Dong; Zhi Hao Wang; Bin Dong; Ya Nan Hu; Hui Ying Zhao
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.